Strides Pharma Science Limited Overview
Pro stress-test →Strides is a global pharmaceutical company that makes high-quality, affordable generic medicines for markets across the world. The company's pharmaceutical products are sold in over 100 countries. The company specializes in niche, technically complex formulations with a significant global manufacturing footprint.
Strategic Profile
Pro stress-test →Strides operates in development and manufacturing of pharmaceutical products and has emerged as one of the world's leading producers of soft gelatin capsules. The company has followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure. The company balances portfolio growth with manufacturing excellence across regulated and emerging markets.
Competitive Landscape
Pro stress-test →Strides' generic pharma business is driven by IP-based product licensing and global marketing partnerships, specializing in manufacturing niche generic formulations in various dosage forms focusing on regulated markets including the United States, Europe, Australia, etc. The company competes in the specialized generic pharmaceuticals segment against larger multinational and emerging market competitors, differentiating through manufacturing expertise and soft gelatin capsule capabilities.
Industry Context
Strides Pharma Science Limited operates in Pharmaceuticals & Biotechnology - Generic Pharmaceuticals / Specialty Formulations.
Key facts
Founded: 1990 · Headquarters: Bengaluru, India · Employees: 3,301 · Revenue: $545.6M (2025) · Market cap: $881M / ₹7,849-8,015 Cr